- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 7 residues within 4Å:- Chain A: F.20, L.21, S.23, C.31, T.32, Y.33, P.49
Ligand excluded by PLIPEDO.3: 8 residues within 4Å:- Chain A: K.39, S.147, P.157, I.158, E.178, V.179, R.180, E.192
Ligand excluded by PLIPEDO.4: 2 residues within 4Å:- Chain A: S.167, S.168
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: Q.7, L.37, N.38, K.71, L.159, F.177, E.178
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: R.17, L.18, G.19, W.53
- Ligands: ACT.7
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain B: F.20, L.21, S.23, C.31, T.32, Y.33, P.49
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain B: K.39, S.147, P.157, I.158, E.178, V.179, R.180, E.192
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain B: S.167, S.168
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain B: R.17, L.18, G.19, W.53
- Ligands: ACT.14
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain B: Q.7, L.37, N.38, K.71, L.159, F.177, E.178
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain D: F.20, L.21, S.23, C.31, T.32, Y.33, P.49
Ligand excluded by PLIPEDO.17: 8 residues within 4Å:- Chain D: K.39, S.147, P.157, I.158, E.178, V.179, R.180, E.192
Ligand excluded by PLIPEDO.18: 2 residues within 4Å:- Chain D: S.167, S.168
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain D: Q.7, L.37, N.38, K.71, L.159, F.177, E.178
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain D: R.17, L.18, G.19, W.53
- Ligands: ACT.21
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain E: F.20, L.21, S.23, C.31, T.32, Y.33, P.49
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain E: K.39, S.147, P.157, I.158, E.178, V.179, R.180, E.192
Ligand excluded by PLIPEDO.25: 2 residues within 4Å:- Chain E: S.167, S.168
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain E: R.17, L.18, G.19, W.53
- Ligands: ACT.28
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain E: Q.7, L.37, N.38, K.71, L.159, F.177, E.178
Ligand excluded by PLIP- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.7: 5 residues within 4Å:- Chain A: L.18, G.19, F.20, Y.33
- Ligands: EDO.6
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.20, A:Y.33
- Hydrogen bonds: A:Y.33
- Water bridges: A:L.18, A:L.18, A:Y.33
ACT.14: 5 residues within 4Å:- Chain B: L.18, G.19, F.20, Y.33
- Ligands: EDO.12
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.20, B:Y.33
- Hydrogen bonds: B:Y.33
- Water bridges: B:L.18, B:L.18, B:Y.33
ACT.21: 5 residues within 4Å:- Chain D: L.18, G.19, F.20, Y.33
- Ligands: EDO.20
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:F.20, D:Y.33
- Hydrogen bonds: D:Y.33
- Water bridges: D:L.18, D:L.18, D:Y.33
ACT.28: 5 residues within 4Å:- Chain E: L.18, G.19, F.20, Y.33
- Ligands: EDO.26
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:F.20, E:Y.33
- Hydrogen bonds: E:Y.33
- Water bridges: E:L.18, E:L.18, E:Y.33
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Golovenko, D. et al., New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins. Structure (2018)
- Release Date
- 2018-06-13
- Peptides
- Cellular tumor antigen p53: ABDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BD
AE
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Golovenko, D. et al., New Insights into the Role of DNA Shape on Its Recognition by p53 Proteins. Structure (2018)
- Release Date
- 2018-06-13
- Peptides
- Cellular tumor antigen p53: ABDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BD
AE
B